Gennadiy Koev
AbbVie (United States)(US)
Publications by Year
Research Areas
Hepatitis C virus research, HIV/AIDS drug development and treatment, Hepatitis B Virus Studies, Plant Virus Research Studies, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Exploratory Study of Oral Combination Antiviral Therapy for Hepatitis C(2013)285 cited
- → Synthesis of Subgenomic RNAs by Positive-Strand RNA Viruses(2000)207 cited
- → In Vitro and In Vivo Antiviral Activity and Resistance Profile of Ombitasvir, an Inhibitor of Hepatitis C Virus NS5A(2014)130 cited
- → Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology(2007)129 cited
- → Discovery of ABT-267, a Pan-Genotypic Inhibitor of HCV NS5A(2014)126 cited
- → Mutations Conferring Resistance to a Hepatitis C Virus (HCV) RNA-Dependent RNA Polymerase Inhibitor Alone or in Combination with an HCV Serine Protease Inhibitor In Vitro(2005)120 cited
- → In Vitro Activity and Resistance Profile of Dasabuvir, a Nonnucleoside Hepatitis C Virus Polymerase Inhibitor(2014)119 cited
- → A Positive-Strand RNA Virus with Three Very Different Subgenomic RNA Promoters(2000)81 cited
- → A phase 2a trial of 12-week interferon-free therapy with two direct-acting antivirals (ABT-450/r, ABT-072) and ribavirin in IL28B C/C patients with chronic hepatitis C genotype 1(2013)69 cited
- → Primary and Secondary Structural Elements Required for Synthesis of Barley Yellow Dwarf Virus Subgenomic RNA1(1999)65 cited